- Translation - 9 August 2018 Subject: Management’s Discussion and Analysis for the Operating Results of the Second Quarter of 2018 Attention: The President of the Stock Exchange of Thailand Exotic
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
: Case 1: Committing a fraud by misappropriating IEC assets through a purchase transaction of IEC Sakaeo 1 Co., Ltd. (SK1) shares at the amount of 345 million baht. Suthin and Charuwan sold the shares and
also had a forex loss of Baht 5 . 1 3 million, which was a loss on foreign exchange. The need to improve foreign debtors' accounts at the end of the year was due to the continued appreciation of the baht
and services income, net 1,275,577 1,130,742 144,835 12.8 Gain on financial instruments measured at fair value through profit or loss 459,381 0 459,381 n.a. Gain on trading and foreign exchange
Securities and Exchange Commission No. Or Thor. 21/2543 Re: Guidelines for the Operating Control of Brokerage and Dealing of Securities That Are Not Debt Instruments _____________________________ For the
Extraordinary General Meeting of Shareholders No.1/2019 (EGM 1/2019) To: The President of the Stock Exchange of Thailand Attachment: 1. Information Memorandum of the Purchase and Acquisition of Entire Business
achieve a core operating profit of Baht 422.68 million in Q1 2021. Gain on foreign currency exchange rate was at Baht 102.37 million in Q1 2021, compared to a gain of Baht 198.68 million in Q1 2020, caused